While in electrical engineering, automated measurements may typically take in the order of microseconds to minutes, within bio-engineering, measurements taking hours to months are more common. Hence, technological innovations result in new versions of laptops, tablets, smartphones, etc. every year, while medical innovations leading to new drugs take about 13 years. As a result, drug development is very expensive, entails high risks, and currently does not allow us to deal properly with health emergencies like Ebola, or societal challenges like healthy ageing in times of governmental budget restrictions. But then, what happens if you bring those fields of electrical and bio-engineering together?
At BiosenSource, we aim to drive drug discovery by developing electronics-based measurement devices and data analysis software that excel in terms of speed, accuracy and user-friendliness.
Our first device, called BISense, will allow researchers in academia, biotech and pharma to study interactions between biomolecules, such as protein-DNA, and protein-protein interactions, in a faster and simpler manner than possible today, impacting both fundamental research -i.e., understanding diseases- and drug discovery.